Cilo Cybin Holdings (JSE:CCC) Debt-to-EBITDA : 0.00 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cilo Cybin Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was R0.00 Mil. Cilo Cybin Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was R0.00 Mil. Cilo Cybin Holdings's annualized EBITDA for the quarter that ended in Sep. 2024 was R1.87 Mil. Cilo Cybin Holdings's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cilo Cybin Holdings's Debt-to-EBITDA or its related term are showing as below:

JSE:CCC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.56 Med: -0.56 Max: -0.56
Current: -0.56

During the past 2 years, the highest Debt-to-EBITDA Ratio of Cilo Cybin Holdings was -0.56. The lowest was -0.56. And the median was -0.56.

JSE:CCC's Debt-to-EBITDA is ranked worse than
100% of 679 companies
in the Drug Manufacturers industry
Industry Median: 1.62 vs JSE:CCC: -0.56

Cilo Cybin Holdings Debt-to-EBITDA Historical Data

The historical data trend for Cilo Cybin Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cilo Cybin Holdings Debt-to-EBITDA Chart

Cilo Cybin Holdings Annual Data

Trend

Mar22

Mar23

Debt-to-EBITDA

N/A

-0.56

Cilo Cybin Holdings Semi-Annual Data
	Mar22	Mar23	Sep23	Sep24
Debt-to-EBITDA	N/A	N/A	-	-

Competitive Comparison of Cilo Cybin Holdings's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cilo Cybin Holdings's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cilo Cybin Holdings's Debt-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Cilo Cybin Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cilo Cybin Holdings's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.302	+	0)	/	-0.54
	=	-0.56

Cilo Cybin Holdings's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0	+	0)	/	1.872
	=	0.00

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2024) EBITDA data.

Cilo Cybin Holdings (JSE:CCC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Cilo Cybin Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Cilo Cybin Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157

Website

https://www.cilocybin.com

Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines